Lurasidone
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 872 publications
A novel sequential ketamine and D-cycloserine/lurasidone therapy for bipolar depression with acute suicidal ideation.
Journal: Expert opinion on investigational drugs
Published: May 21, 2026
Vortioxetine-Lurasidone Augmentation for Compulsive Scratching Behavior in Prader-Willi Syndrome: A Case Report.
Journal: Neuropsychopharmacology reports
Published: April 25, 2026
Pharmacological treatment of schizophrenia: Japanese Expert Consensus 2025.
Journal: Schizophrenia (Heidelberg, Germany)
Published: April 03, 2026
Dose-dependent modulation of social and motivational behavior by lurasidone in a rat model of social defeat.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: April 02, 2026
Antipsychotics in Children and Adolescents with Schizophrenia-Spectrum Disorders: A Systematic Review, Meta-Analysis, and Long-Term Prospective Evidence.
Journal: Journal of child and adolescent psychopharmacology
Published: March 10, 2026
Post-Psychotic Depression: A Comprehensive Narrative Review.
Journal: Diseases (Basel, Switzerland)
Published: March 10, 2026
Real world pharmacovigilance assessment of drug related perinatal depression risks.
Journal: Frontiers in pharmacology
Published: March 01, 2026
Dose-response considerations in transdiagnostic antidepressant effects of lurasidone: response to Chen et al: commentary, Ghenciulescu & De Giorgi.
Journal: The British journal of psychiatry : the journal of mental science
Published: February 27, 2026
Efficacy and safety of pharmacological interventions for the maintenance of bipolar disorder: A systematic review and dose-related network meta-analysis across different age groups.
Journal: Journal of affective disorders
Published: February 16, 2026
Impact of valproate co-medication and age on lurasidone exposure: a population pharmacokinetic study and real-world evaluation in Chinese psychiatric inpatients.
Journal: Frontiers in pharmacology
Published: February 13, 2026
Antipsychotic treatment patterns and cardiometabolic medicine use: current real-world evidence.
Journal: Epidemiology and psychiatric sciences
Published: February 11, 2026
Mechanism-Based Polypharmacy as a Repurposing Strategy: The Case of D-Cycloserine and Lurasidone.
Journal: Clinical and translational science
Published: February 08, 2026
Last Updated: 06/30/2026